Wanbury Ltd. Launches Next-Generation Liposomal Iron Supplement 'Wanbury C RED' to Combat Anemia

Wanbury Limited, a leading pharmaceutical company, has successfully launched a next-generation Liposomal Iron formulation, 'Wanbury C RED', designed to revolutionize anemia management in India. The product, which ensures enhanced absorption and minimal metallic aftertaste, has already garnered tremendous response from clinicians/doctors in Northern and Southern India, resulting in substantial early uptake. Encouraged by the initial success, Wanbury aims to scale up distribution Pan-India in the first few months of the launch. The launch of 'Wanbury C RED' marks the company's reentry into the gynaecology segment, where it earlier had a successful brand, 'C Pink', which was divested to Cipla Limited a few years ago.